CLSD CLEARSIDE BIOMEDICAL INC Management Changes 8-K Filing 2023 - Resignation and Appointment Clearside Biomedical, Inc. announces the resignation of Thomas Ciulla as Chief Medical Officer and Chief Development Officer, and his appointment as Chairman of the Scientific Advisory Board and Chief Medical Advisor Retina, with a monthly fee of $8,000 per month.Get access to all SEC 8-K filings of the CLEARSIDE BIOMEDICAL INC